Articles

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study

Registre des Hémopathies Malignes de Côte d'Or, EA 4184, Université de Bourgogne; Service d'Hématologie Biologique, CHU de Dijon, France
National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy
Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, and Catalan Institute of Oncology, Girona, Spain
Comprehensive Cancer Centre, Utrecht, the Netherlands
Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;Cancer Research UK Cancer Survival Group, Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London UK
Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy
Biella Cancer Registry, Italy
Geneva Cancer Registry and NICER Network, Switzerland
Center for Public Health Research, Valencia, Spain
Finnish Cancer Registry, Helsinki, Finland
Norwegian Cancer Registry, Oslo, Norway
National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy
Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;HAEMACARE project leader
Vol. 98 No. 2 (2013): February, 2013 https://doi.org/10.3324/haematol.2012.064014